TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
3.8. Product Pipeline Analysis
3.9. Incidence and Prevalence Analysis
3.10. Patent Analysis
4. TECHNOLOGICAL OUTLOOK
5. MACHINE LEARNING BASED DIAGNOSTIC IMAGING PLATFORMS MARKET BY COMPONENT
5.1. Introduction
5.2. Software
5.3. Hardware
5.4.Services
6. MACHINE LEARNING BASED DIAGNOSTIC IMAGING PLATFORMS MARKET BY IMAGING MODALITY
6.1. Introduction
6.2. X ray
6.3. Computed Tomography (CT)
6.4. Magnetic Resonance Imaging (MRI)
6.5. Ultrasound
6.6. Positron Emission Tomography (PET)
6.7.Mammography
7. MACHINE LEARNING BASED DIAGNOSTIC IMAGING PLATFORMS MARKET BY APPLICATION
7.1. Introduction
7.2. Oncology
7.3. Cardiology
7.4. Neurology
7.5. Orthopedics
7.6. Pulmonology
8. MACHINE LEARNING BASED DIAGNOSTIC IMAGING PLATFORMS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Siemens Healthineers
10.2. GE HealthCare
10.3. Philips Healthcare
10.4. Canon Medical Systems
10.5. Fujifilm Healthcare
10.6. IBM Watson Health
10.7. Aidoc
10.8. Zebra Medical Vision
10.9. Tempus
10.10. Butterfly Network
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES